Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%

Trials by Status

completed267%
active_not_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
completed

Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection

NCT04369807
active_not_recruiting

Contrast-Free Magnetic Resonance Imaging for Breast Disease

NCT05006196
completed

Developing an US-MRI Biomarker Fusion Model for Endometriosis

NCT04974710

Clinical Trials (3)

Showing 3 of 3 trials
NCT04369807

Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection

Completed
NCT05006196

Contrast-Free Magnetic Resonance Imaging for Breast Disease

Active Not Recruiting
NCT04974710

Developing an US-MRI Biomarker Fusion Model for Endometriosis

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3